Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease.

Sleep medicine·2016
Same author

Pulmonary manifestations of extrathoracic malignant lesions.

Mayo Clinic proceedings·1993
Same author

Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features.

Chest·1990
Same author

Severe complications of intravenous phytonadione therapy. Two cases, with one fatality.

Postgraduate medicine·1982
Same author

Adult respiratory distress syndrome due to salicylate intoxication.

Minnesota medicine·1982
Same author

Cavitating coccidioidomycosis complicated by a second cavitating pneumonia.

Minnesota medicine·1981

Related Experiment Video

Updated: Jul 14, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Occupational lung cancer

P L Whitesell1, C W Drage

  • 1Division of Thoracic Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

Mayo Clinic Proceedings
|February 1, 1993
PubMed
Summary

Industrial agents like asbestos, chromium, nickel, and radon may pose carcinogenic risks. Minimizing occupational exposure to these lung carcinogens is crucial for prevention, despite ongoing scientific debate.

Area of Science:

  • Occupational Health
  • Environmental Toxicology
  • Cancer Epidemiology

Background:

  • Industrial agents are suspected of having carcinogenic potential for workers and the general population.
  • Determining carcinogenicity involves case reports, lab studies, and epidemiology, each with limitations in establishing causality.
  • Asbestos, chromium, nickel, and radon are linked to lung cancer, but risk factors like dose and co-carcinogens are debated.

Purpose of the Study:

  • To review the evidence and controversies surrounding the carcinogenic potential of industrial agents, particularly in relation to lung cancer.
  • To highlight the complexities in assessing the risk magnitude and causal associations.
  • To emphasize the importance of exposure minimization for cancer prevention.

Main Methods:

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jul 14, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

  • Review of existing literature, including case reports, laboratory studies, and epidemiological analyses.
  • Analysis of factors influencing carcinogenicity, such as agent type, exposure dose, and co-exposures.
  • Examination of controversial aspects in assessing occupational lung cancer risks.

    • Main Results:

    • Asbestos is linked to bronchogenic carcinoma, with dose-response, co-carcinogen effects, and threshold doses being areas of controversy.
    • Other agents like chromium, nickel, and radon show associations with increased lung cancer incidence in studies.
    • Findings for man-made mineral fibers, formaldehyde, and silica are inconsistent, indicating complexity in risk assessment.

    Conclusions:

    • The health risks of asbestos and other suspected lung carcinogens are subject to ongoing scientific debate and varying opinions.
    • Understanding the specific agent and exposure conditions is critical for determining carcinogenicity.
    • Preventing lung cancer through reduced or eliminated exposure to carcinogens is a recommended public health strategy.